Skip to navigation Skip to content



About this Medication
  • Brand Name: Tecfidera® (U.S.) (teck-fi-DARE-ah)
  • Chemical Name: dimethyl fumarate (dye-METH-il FOO-mah-rate)
  • Usage in MS: Disease-Modifying Agent
  • Generic Available: No

This is an oral medication in capsule form.


Tecfidera® is an oral therapy contained in capsules taken two times per day. Tecfidera, formerly known as BG-12, is dimethyl fumarate, a formulation that was developed specifically for use by people with multiple sclerosis. A chemically related compound, called Fumaderm (dimethyl fumarate and fumaric acid esters), has been used at higher doses for decades in Germany to treat acute flare-ups of psoriasis. Although its exact mechanism of action is not known, Tecfidera is thought to inhibit immune cells and molecules, and may have anti-oxidant properties that could be protective against damage to the brain and spinal cord.

Tecfidera is approved by the FDA for the treatment of relapsing forms of multiple sclerosis, which include clinically isolated syndrome, relapsing-remitting disease (RRMS) and active secondary progressive disease (SPMS with relapses).

Click here to read the Tecfidera Prescribing Information for healthcare professionals.

Click here to read the Tecfidera Patient Information.


Patient Support Program: Above MS

Financial Assistance Program

Above MS


What You Need To Know About Tecfidera®

Published June 11, 2013
MS Learn Online is the National MS Society's online educational webcast series. This video features Dr. Bruce Cohen and Dr. Gabriel Pardo discussing the latest disease modifying treatment Tecfidera®. To learn more about Tecfidera® and other disease modifying treatment options, download the Consensus on Disease-Modifying Therapies and summary.

Watch Now


Your input is important!

We believe that people affected by MS live better lives when they're connected.  To help us provide you with the best resources, support and information, please provide your feedback in a short survey.
Take the survey